Canara Bank has scheduled a Board Meeting for September 3, 2026, to consider raising foreign currency funds through the issuance of Senior Unsecured Foreign Currency Bonds or Medium Term Notes (MTNs). The issuance would be executed under the bank’s existing MTN Programme.

The meeting aims to approve this specific capital raising activity. No other agenda items were disclosed in the intimation sent to stock exchanges.

Trading Window Closure

In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the bank’s Code of Conduct for Prohibition of Insider Trading, the trading window for directors, designated persons, their relatives, and connected persons will remain closed.

The closure period runs from August 31, 2026, through September 5, 2026, inclusive. This restriction applies to dealing in shares or securities of the bank during this interval.

Regulatory Compliance

The intimation was issued under Regulation 29 and Regulation 50 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice was signed by Santosh Kumar Barik, Company Secretary, on August 29, 2026.

The Board of Directors of Canara Bank has approved the sale of its 70% stake in unlisted subsidiary Canbank Factors Limited to Vidvedaa Private Limited. The transaction is valued at ₹80.50 crore and awaits necessary regulatory and statutory approvals.

The decision was taken during a board meeting held on August 29, 2026. The sale involves the transfer of 100% equity shares of the subsidiary company to the buyer.

Transaction Details

The deal marks a strategic divestment for the public sector lender. Key terms of the agreement include:

The bank informed stock exchanges about the move via a disclosure letter dated August 29, 2026. The reference cited was a previous communication from November 28, 2023, regarding subsidiaries.

What the Numbers Show

The fixed consideration of ₹80.50 crore for a 70% stake implies a total implied valuation of approximately ₹115 crore for Canbank Factors Limited, though this figure is not explicitly stated in the filing. The transaction remains contingent on external regulatory clearances, meaning no cash inflow or accounting impact will be recognized until those conditions are met.